Status:
ACTIVE_NOT_RECRUITING
Multiple Myeloma Molecular Monitoring Study
Lead Sponsor:
Horizon Health Network
Conditions:
Multiple Myeloma
Eligibility:
All Genders
19-99 years
Brief Summary
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hy...
Detailed Description
Multiple myeloma (MM) is a deadly cancer of the bone marrow that is challenging to manage and treat: the drugs that are currently available attack the cancer in the same way for everyone, but each pat...
Eligibility Criteria
Inclusion
- Ability to give informed consent
- Diagnosed with active multiple myeloma
- Consented to participation in Myeloma Canada Research Network (MCRN) database project
- Previously untreated and eligible for autologous stem-cell transplantation (ASCT)
Exclusion
- Ineligible for ASCT
- Does not consent to participate in MCRN database project
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2026
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT03421132
Start Date
February 20 2018
End Date
March 31 2026
Last Update
June 29 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
2
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
3
Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1M9
4
CancerCare Manitoba
Winnipeg, Manitoba, Canada, R3E 0V9